Across TCGA pan-cancer cohorts, MIR1203 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR1203’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where MIR1203 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR1203 is over-expressed in tumor, although a few such as KIRC show the opposite, repressed pattern.

KIRP, KIRC, and BRCA are the cancer types where MIR1203 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1203 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.292	.008	3	view →
KIRC	All	IV	−0.180	.043	2	view →
BRCA	Female	All	+0.126	.035	2	view →
COAD	All	All	+0.123	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR1203 RNA expression & survival · all MIR1203 data types